Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Role of 18F-FDG PET/CT in the diagnosis of clinically suspected Marjolin ulcer.

Ko Y, Han YM, Hwang HS, Kang IW, Hwang DH, Lee ES, Lee GK.

AJR Am J Roentgenol. 2012 Dec;199(6):1375-9. doi: 10.2214/AJR.11.8398.

PMID:
23169733
2.

Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.

Chae EY, Cha JH, Kim HH, Shin HJ, Kim HJ, Oh HY, Koh YH, Moon DH.

Acta Radiol. 2012 Jun 1;53(5):530-5. doi: 10.1258/ar.2012.120015. Epub 2012 May 16.

PMID:
22593124
3.
4.
5.

Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.

Moon SH, Kim HS, Hyun SH, Choi YS, Zo JI, Shim YM, Lee KH, Kim BT, Choi JY.

J Nucl Med. 2014 May;55(5):743-8. doi: 10.2967/jnumed.113.130716. Epub 2014 Apr 3.

6.

Total lesion glycolysis as the best 18F-FDG PET/CT parameter in differentiating intermediate-high risk adrenal incidentaloma.

Kim YI, Cheon GJ, Paeng JC, Cho JY, Kang KW, Chung JK, Kim EE, Lee DS.

Nucl Med Commun. 2014 Jun;35(6):606-12. doi: 10.1097/MNM.0000000000000101.

PMID:
24598843
7.

Role of SUV(max) obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation.

Hu SL, Yang ZY, Zhou ZR, Yu XJ, Ping B, Zhang YJ.

Nucl Med Commun. 2013 Jun;34(6):533-9. doi: 10.1097/MNM.0b013e328360668a.

PMID:
23503000
8.

18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.

Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF.

J Nucl Med. 2005 Jul;46(7):1136-43.

9.

Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.

Perri M, Erba P, Volterrani D, Guidoccio F, Lazzeri E, Caramella D, Mariani G.

AJR Am J Roentgenol. 2011 Jul;197(1):209-16. doi: 10.2214/AJR.10.5342.

PMID:
21701032
10.

Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.

Xu R, Kido S, Suga K, Hirano Y, Tachibana R, Muramatsu K, Chagawa K, Tanaka S.

Ann Nucl Med. 2014 Nov;28(9):926-35. doi: 10.1007/s12149-014-0895-9. Epub 2014 Aug 9.

PMID:
25107363
11.

The role of FDG PET-CT in differential diagnosis of pleural pathologies.

Elboga U, Yılmaz M, Uyar M, Zeki Çelen Y, Bakır K, Dikensoy O.

Rev Esp Med Nucl Imagen Mol. 2012 Jul-Aug;31(4):187-91. doi: 10.1016/j.remn.2011.06.002. Epub 2011 Sep 22.

12.

Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT.

Rahbar K, Seifarth H, Schäfers M, Stegger L, Hoffmeier A, Spieker T, Tiemann K, Maintz D, Scheld HH, Schober O, Weckesser M.

J Nucl Med. 2012 Jun;53(6):856-63. doi: 10.2967/jnumed.111.095364. Epub 2012 May 10.

13.

Comparison of MR imaging and FDG-PET/CT in the differential diagnosis of benign and malignant vertebral compression fractures.

Cho WI, Chang UK.

J Neurosurg Spine. 2011 Feb;14(2):177-83. doi: 10.3171/2010.10.SPINE10175. Epub 2011 Jan 7.

PMID:
21214309
14.

Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography.

D'Souza MM, Marwaha RK, Sharma R, Jaimini A, Thomas S, Singh D, Jain M, Bhalla PJ, Tripathi M, Tiwari A, Mishra A, Mondal A, Tripathi RP.

Ann Nucl Med. 2010 Jun;24(5):345-55. doi: 10.1007/s12149-010-0357-y. Epub 2010 Apr 7.

PMID:
20373060
15.

[Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].

Xu XX, Cheng J, Xu WG, Dai D, Song XY, Ma WC, Zhu L, Zhu X.

Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):364-8. doi: 10. 3760/cma.j.issn.0253-3766.2012.05.010. Chinese.

PMID:
22883458
16.

Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?

Kendi AT, Magliocca K, Corey A, Nickleach DC, Galt J, Higgins K, Beitler JJ, El-Deiry MW, Wadsworth JT, Hudgins PA, Saba NF, Schuster DM.

Clin Nucl Med. 2015 Mar;40(3):e196-200. doi: 10.1097/RLU.0000000000000691.

17.

Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.

Santhosh S, Mittal BR, Bhasin D, Srinivasan R, Rana S, Das A, Nada R, Bhattacharya A, Gupta R, Kapoor R.

J Gastroenterol Hepatol. 2013 Feb;28(2):255-61. doi: 10.1111/jgh.12068.

PMID:
23278193
18.

Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.

Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.

Invest Radiol. 2013 May;48(5):247-55. doi: 10.1097/RLI.0b013e31828d56a1.

PMID:
23519008
19.

Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.

Murakami R, Uozumi H, Hirai T, Nishimura R, Shiraishi S, Ota K, Murakami D, Tomiguchi S, Oya N, Katsuragawa S, Yamashita Y.

Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):377-82. Epub 2007 Feb 22.

PMID:
17321066
20.

Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.

Yokoyama R, Miyagawa M, Okayama H, Inoue T, Miki H, Ogimoto A, Higaki J, Mochizuki T.

Int J Cardiol. 2015 Sep 15;195:180-7. doi: 10.1016/j.ijcard.2015.05.075. Epub 2015 May 15.

PMID:
26043154

Supplemental Content

Support Center